One of the many studies reported on this week at the American Heart Association Scientific Sessions in New Orleans was about an ablation catheter clinical trial (from Biosense Webster) that may finally usher in the first FDA approval of a device for treating atrial fibrillation. Read why this could be good news for anyone with atrial fibrillation.
Request for FDA Approval of Catheter for Atrial Fibrillation Ablation May Usher in Sea Change
Pingback: FDA Approves First Device for Treating Atrial Fibrillation | Atrial Fibrillation Blog